Bottom line Retatrutide may be associated with tiredness in some participants
However, more than half of this cohort, 56%, said that if cost and availability were not an issue, they would begin using GLP-1 medications for weight loss
Many people report that food no longer drives their thoughts or behavior in the same way. In 2012, Skibickas lab was the first to demonstrate reduced alcohol reward and motivation in animal models treated with a GLP-1 analog
Semaglutide Regulatory Status in Canada Health Canada Approval Status (Ozempic, Wegovy, Rybelsus, Generic) Semaglutide is the active ingredient in three Novo Nordisk products authorized for sale in Canada: Ozempic (authorized 2018 for type 2 diabetes, with an expanded indication in 2024 to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes), Rybelsus (oral semaglutide tablets authorized for type 2 diabetes), and Wegovy (authorized 2021 for chronic weight management, with an expanded indication in 2024 to reduce the risk of non-fatal myocardial infarction, and a Notice of Compliance with Conditions issued in December 2025 for non-cirrhotic metabolic dysfunction-associated steatohepatitis with moderate to advanced liver fibrosis)
